Repay (RPAY) Q1 2025 Earnings Call Transcript

Repay Holdings reported Q1 revenue of $77.3 million, down 4% year over year, with gross profit down 5% and adjusted EBITDA of $33.2 million (43% margin). Free cash flow was negative $8 million due to $16 million of working-capital timing and $3 million of client-loss impacts, but liquidity remained strong at $415 million and net leverage was 2.5x. Management ended its strategic review, raised the share repurchase authorization to $75 million, and guided for sequential gross profit improvement with Q4 exit-rate growth of high single digits to low double digits and free cash flow conversion above 60% by year-end.

Analysis

RPAY is signaling a classic “clean-up year” where the reported top line remains noisy, but the operating lever is actually the mix of lapping legacy attrition plus a deliberate pivot toward higher-quality, enterprise-led throughput. The important second-order read: if management is right that client-loss drag is mostly anniversarying out and the new sales motion is already in the field, then 2H acceleration could look more like a reset of the denominator than a true demand inflection. That means the market may be underestimating how quickly gross profit can re-rate if implementation bottlenecks ease, because the business has very high operating leverage once volume returns.

The strategic-review conclusion is the key signal. Rather than a near-term M&A monetization story, the company is now effectively a self-help story with buybacks as a backstop and the 2026 convert as the overhang to watch. In that context, the increase in repurchase authorization is less about aggressive capital return and more about management putting a floor under the equity while preserving flexibility for refinancing; if execution improves even modestly, the combination of lower share count and eventual deleveraging can compound equity value faster than headline revenue growth suggests.

The bear case is that the turnaround depends on execution in enterprise sales and faster implementation cycles, which are exactly the areas most vulnerable to macro hesitation and management turnover. The CFO transition adds governance noise at the same time the company is asking investors to underwrite a second-half inflection, so the stock likely needs evidence rather than promises. The consensus risk is underappreciating how much of the growth math is tied to lumpy client anniversaries and non-recurring working capital dynamics; if those normalize, the apparent “reacceleration” could be mechanically real, but if they don’t, the market will punish the stock for missing a very back-half-loaded plan.

Key Decisions for Investors

• Long RPAY common into the next 1-2 quarters only as a catalyst trade, not a secular compounder: risk/reward improves if gross profit inflects toward low-single-digit ex-loss growth by Q2/Q3; trim aggressively if sequential improvement stalls.
• Pair trade: long RPAY / short a slower-moving fintech processor with less self-help optionality (e.g., FIS or GPN) over the next 3-6 months; thesis is RPAY has cleaner operating leverage while the short leg is more exposed to lower-growth, longer-duration rerating risk.
• Buy RPAY 6-12 month call spreads rather than stock if using options; the setup is a second-half execution story with defined downside from CFO transition and convert overhang, but meaningful upside if buybacks and margin stabilization compress the multiple.
• Watch the 2026 convertible as the real event risk: if shares fail to re-rate and cash conversion does not improve by mid-year, consider a short RPAY/long cash-flow-quality fintech pair into any rally, because refinancing complexity can cap upside well before 2026.
• Do not chase the name solely on the buyback authorization; wait for evidence of faster enterprise implementation and normalized free cash flow conversion above 50% in Q2 before adding size.